Meng‐Xin Tian
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Jia Fan (28 shared papers)Ying–Hong Shi (29 shared papers)Wei‐Ren Liu (21 shared papers)Jian Zhou (22 shared papers)Zhen‐Bin Ding (20 shared papers)Lei Jin (16 shared papers)Yuan‐Fei Peng (17 shared papers)Xi‐Fei Jiang (20 shared papers)
- Journals
- Journal of Cancer (4 papers)Oncotarget (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)BMC Cancer (2 papers)Oncogene (1 paper)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Meng‐Xin Tian
36 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 265
- Hepatology 91
- Oncology 256
- Cell Biology 139
- Immunology 127
Countries citing papers authored by Meng‐Xin Tian
This map shows the geographic impact of Meng‐Xin Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Xin Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Xin Tian more than expected).
Fields of papers citing papers by Meng‐Xin Tian
This network shows the impact of papers produced by Meng‐Xin Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Xin Tian. The network helps show where Meng‐Xin Tian may publish in the future.
Co-authors
The 25 scholars most cited alongside Meng‐Xin Tian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 104 | |
| 2 | 2015 | 94 | |
| 3 | 2014 | 82 | |
| 4 | 2019 | 72 | |
| 5 | 2021 | 48 | |
| 6 | 2016 | 46 | |
| 7 | 2016 | 43 | |
| 8 | 2020 | 40 | |
| 9 | 2019 | 36 | |
| 10 | 2015 | 36 | |
| 11 | 2023 | 30 | |
| 12 | 2024 | 30 | |
| 13 | 2014 | 30 | |
| 14 | 2019 | 30 | |
| 15 | 2020 | 29 | |
| 16 | 2014 | 28 | |
| 17 | 2020 | 27 | |
| 18 | 2019 | 24 | |
| 19 | 2016 | 24 | |
| 20 | 2020 | 20 |
About Meng‐Xin Tian
Meng‐Xin Tian is a scholar working on Surgery, Oncology, Cancer Research, Molecular Biology and Immunology, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Gallbladder and Bile Duct Disorders (4 papers), Lipid metabolism and biosynthesis (3 papers), Immune cells in cancer (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Cancer Research (265 citations), Hepatology (91 citations), Oncology (256 citations), Cell Biology (139 citations) and Immunology (127 citations). Meng‐Xin Tian has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jia Fan, Ying–Hong Shi, Wei‐Ren Liu, Jian Zhou, Zhen‐Bin Ding, Lei Jin, Yuan‐Fei Peng, Xi‐Fei Jiang, Zhi Dai and Pei‐Yun Zhou. Their work appears in journals such as Journal of Cancer, Oncotarget, Journal for ImmunoTherapy of Cancer, BMC Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.